Alzheimer’s Association International Conference (AAIC) 2020

Infection may increase mortality risk in dementia

Elvira Manzano, 20200828100000

Post-infection mortality is higher in older patients with dementia than those without in an analysis of Danish national registry data presented at AAIC 2020.

Apnoea or habitual long sleep doubles AD risk

Elvira Manzano, 20200828090000

Having sleep apnoea or sleeping more than 9 hours every night doubles the risk of developing Alzheimer’s disease (AD) in middle-aged individuals within 6 years in a new study.

Some antihypertensive meds tied to lower dementia risk

Roshini Claire Anthony, 20200820200002

Calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs) may be associated with a reduced risk of dementia, according to a systematic review and network meta-analysis conducted by researchers from the Netherlands.

Pimavanserin may cut symptoms of dementia-related psychosis

Audrey Abella, 20200820100000

Use of the antipsychotic drug pimavanserin led to a substantial reduction in psychosis symptoms in individuals with dementia regardless of severity or subtype, according to the results of the HARMONY trial presented at AAIC 2020.

P-tau217: Blood biomarker for diagnosing Alzheimer's?

Plasma P-tau217: Potential biomarker for Alzheimer's?

Pearl Toh, 20200819150000

A new blood test for plasma P-tau217* accurately differentiates Alzheimer's disease (AD) from other neurodegenerative diseases — showing promise as a blood-based biomarker for early detection of AD, according to a study presented at the AAIC 2020 Meeting.

Flu, pneumococcal vaccines may prevent Alzheimer’s disease

Roshini Claire Anthony, 20200817200002

Regular influenza and pneumococcal vaccinations may help stave off the development of Alzheimer’s disease (AD), according to two studies presented at AAIC 2020.

Risk factors for Alzheimer’s may appear early in life

Audrey Abella, 20200817100000

Risk factors for Alzheimer’s disease (AD) may be present as early as adolescence and young adulthood, data presented at AAIC 2020 have shown, highlighting the importance of addressing these factors early in the fight against AD and other dementias.